John McPherson Named ConsentSolutions, Inc. Director of Quality Programs & Services

John McPherson Named ConsentSolutions, Inc. Director of Quality Programs & Services

ConsentSolutions, Inc., a provider of SecureConsent an electronic informed consent technology application for clinical research trials has named John McPherson Director of Quality Programs & Services. John brings over 30 years of global managerial experience covering Quality, Regulatory, IT, Manufacturing, and Engineering in biopharmaceutical/biotechnology start-ups, including validation implementation and continuous improvement of quality systems in associated business areas.

Frederick, MD (PRWEB) June 4, 2009 -- ConsentSolutions, Inc., a provider of SecureConsent, an electronic informed consent technology application for clinical research trials has named John McPherson Director of Quality Programs and Services. John brings over 30 years of global managerial experience covering Quality, Regulatory, IT, Manufacturing, and Engineering in biopharmaceutical/biotechnology start-up, validation implementation and continuous improvement of quality systems and associated business areas.

John will utilize his operational quality & expert knowledge of FDA/ EU GCP, GLP, and GMP regulations and compliance requirements to lead the development of quality programs to expand ConsentSolutions, Inc. products and services offering to include quality regulatory guidance. John will develop and manage Quality Risk Assessment Programs, and also provide oversight of System Development Lifecycle (SDLC) Document and Change Control systems, as well as Quality Audit programs for both internal and external clients.

John most recently served as the Senior Director of Validation and Commercial Quality for Amylin Pharmaceuticals, Inc. where he developed a Corporate Validation Program and oversaw the commercial quality activities of Amylin's global contract service providers.

"I look forward to working for ConsentSolutions to provide comprehensive, compliant quality systems to our clients and allow them to position themselves more competitively in today's market." Says McPherson "Continuous improvement of quality systems are paramount to maintaining a competitive advantage for eRegulatory technology applications" says Jovianna DiCarlo, President & CEO. DiCarlo goes on to say "John is extremely valuable to us with his expertise in the development and implementation of Global Quality Standard Systems so that we can ensure that the SecureConsent application aligns with global quality and regulatory needs".

About ConsentSolutions, Inc
Founded in 2005, headquartered in Frederick, Maryland, with offices in Gaithersburg, ConsentSolutions is focused on adding value to the consenting process through the development of interactive, user-friendly educational software to effectively deliver clinical trial information electronically allowing study candidates to make important decisions about clinical trial participation. With decades of combined experience developing educational multimedia applications, ConsentSolutions, Inc. senior management team is dedicated to the goal of shared decision making for trial participation among study candidates, clinical trial coordinators, investigators, and physicians.

Suggested Articles

Pillar is bankrolling a new accelerator for budding biotechs. Petri aims to serve biotech startups at the “frontier of biology and engineering.”

One of the last major, late-stage attempt at stopping Alzheimer’s using a BACE inhibitor has ended up on the trash pile with so many others.

The oligosaccharide microbiome modulator was no better than placebo at reducing lactose intolerance symptoms.